Drag

Divi's Laboratories Limited

Healthcare DIVISLAB

6289.00INR
336.50 ( 5.65%)

Last update at

Day Range

6150.006304.50
LowHigh

52 Week Range

4932.54 7039.45
LowHigh

Fundamentals

  • Previous Close 5952.50
  • Market Cap 1752225.28M
  • Volume273,626
  • P/E Ratio 70.47
  • EBITDA 32460.00M
  • Revenue TTM 100290.00M
  • Revenue Per Share TTM 377.74
  • Gross Profit TTM 60970.00M
  • Diluted EPS TTM 93.66

Source: TradingView
The charts and visual representations are sourced from TradingView through embedded widgets. For any issues with chart display, please visit the TradingView website

Financials

Income Statement

Total Revenue
Net Income

Balance Sheet

Total Assets
Total Liabilities

Change in Cash

Breakdown 2025-03-31 2024-03-31 2023-03-31 2022-03-31 2021-03-31
Type yearly yearly yearly yearly yearly
Income before tax 29160.00M 21630.00M 23686.30M 36835.00M 26660.40M
Net income 21910.00M 16000.00M 18240.00M 29604.50M 19842.90M
Total Revenue 93580.00M 77960.00M 77488.10M 87992.30M 68583.40M
Gross Profit 31910.00M 45270.00M 44870.00M 57073.50M 45342.60M
Breakdown 2025-03-31 2024-03-31 2023-03-31 2022-03-31 2021-03-31
Type yearly yearly yearly yearly yearly
Date 2025-03-31 2024-03-31 2023-03-31 2022-03-31 2021-03-31
Total assets 169470.00M 154700.00M 144387.70M 133747.10M 107740.70M
Intangible assets 40.00M 40.00M 52.80M 74.90M 49.50M
Other current assets 650.00M 6320.00M 2017.70M 2175.50M 1531.90M
Deferred long term liab - - - - -
Non current assets other - - - - -
Breakdown 2025-03-31 2024-03-31 2023-03-31 2022-03-31 2021-03-31
Type yearly yearly yearly yearly yearly
Date 2025-03-31 2024-03-31 2023-03-31 2022-03-31 2021-03-31
Change in Cash 610.00M 1930.00M -10450.60M -8155.60M 19871.70M
Operating Cash 19460.00M 12610.00M 24597.30M 19118.00M 19469.30M
Free Cash Flow 5080.00M 2580.00M 19867.10M 11986.00M 10367.40M

Peer Comparison

Sector: Healthcare Industry: Drug Manufacturers - Specialty & Generic

Company Change Price Market Cap (M) P/E Ratio
DIVISLAB
Divi's Laboratories Limited 		336.50 5.65% 6289.00 1752225.28 70.47
SUNPHARMA
Sun Pharmaceutical Industries Limited 		75.40 4.63% 1703.30 4224508.76 40.32
TORNTPHARM
Torrent Pharmaceuticals Limited 		39.90 1.00% 4027.10 1362716.66 63.48
CIPLA
Cipla Limited 		16.40 1.25% 1328.00 1183505.97 21.74
DRREDDY
Dr. Reddy's Laboratories Limited 		53.70 4.54% 1236.20 1004813.29 17.16

Profile

Divi's Laboratories Limited engages in the manufacture and sale of generic active pharmaceutical ingredients (APIs), intermediates, and nutraceuticals in India, North America, Asia, Europe, and internationally. The company also undertakes custom synthesis contract manufacturing services of APIs and intermediates; and supplies a range of carotenoids, such as beta carotene, astaxanthin, lycopene, and canthaxanthin, as well as lutein and vitamins used in the food, beverage, dietary supplement, pet food, and feed industries. It also exports its products. The company was formerly known as Divi's Research Center and changed its name to Divi's Laboratories Limited in 1994. Divi's Laboratories Limited was incorporated in 1990 and is based in Hyderabad, India.

Divi's Laboratories Limited

Divi Towers, Hyderabad, India, 500032

Key Executives

Name Title Year Born
Dr. Kiran Satchandra Divi B. Pharm., M.Pharm CEO & Whole-Time Director 1976
Mr. L. Kishore Babu B.Com, FCMA, FICWA Chief Financial Officer 1952
Mr. L. Ramesh Babu LLB, M.Com, MBA VP of Procurement & Chief Information Officer 1957
Mr. M. Satish Choudhury Company Sec. & Compliance Officer NA
Mr. Venkata Ramana Nimmagadda B.Sc.(Chem) Exec. Director 1958
Dr. Murali Krishna Prasad Divi M. Pharm, Ph.D. MD & Exec. Director 1951
Mr. Madhusudana Rao Divi Director of Projects & Whole-Time Director 1944
Mr. M. Ramesh Babu B.Sc. Chief Technologist 1966
Mr. P. Srinivasa Rao M.Pharm Chief Technologist 1965
Ms. Nilima Prasad Divi Whole-time Director & Director of Commercial 1982

Disclaimer - This information, including any data, is sourced from Unicorn Data Services SAS, trading as EOD Historical Data ("EODHD") on an 'as is' basis, using their API. We cannot guarantee the completeness or validity of the information and data provided on this page, as well as via the API. In some cases, the data may include analyst ratings or recommendations sourced through the EODHD API, which are intended solely for general information purposes.
This information does not consider your personal objectives, financial situation, or needs. Kalkine is not liable for any errors or omissions in the information provided or for any actions taken in reliance on it. You should seek advice from a financial adviser, stockbroker or other professional adviser (including taxation and legal advice) as necessary before acting on this information.